MG
SLGC

Michael Gelband’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Michael Gelband’s Portfolio SLGC Stock Details SLGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-419,176
Closed -$3.36M – 2600
2022
Q1 		$3.36M Buy
419,176
+276,148
+193% +$2.44M 0.04% 547
2021
Q4 		$1.67M Buy
+143,028
New +$1.71M 0.02% 839

Other funds holding SLGC

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MAM
Madryn Asset Management New York $36.9M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $362M AUM 386.37% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $329M AUM 64.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Michael Gelband's SLGC Position: Q2 2022 in Review

Michael Gelband sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q2 2022, closing a stake of 419,176 shares — an estimated $3.36M sold.

Michael Gelband first reported a position in SLGC in Q4 2021 and held it in 2 quarters. The position peaked at $3.36M in Q1 2022. 135 funds tracked by Wall St. Rank hold SLGC as of Q2 2022.

  • Michael Gelband reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
  • Michael Gelband sold 419,176 SomaLogic, Inc. Class A Common Stock shares in Q2 2022, an estimated $3.36M.
  • Michael Gelband first reported a position in SomaLogic, Inc. Class A Common Stock in Q4 2021 and held it in 2 quarters.
  • Michael Gelband's SomaLogic, Inc. Class A Common Stock position peaked at $3.36M in Q1 2022.
  • 135 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q2 2022.

Based on ExodusPoint Capital Management's 13F filing for Q2 2022, filed 22 Aug 2022.